PDF herunterladen
Horm Metab Res 2014; 46(12): 854-862
DOI: 10.1055/s-0034-1384519
Review
© Georg Thieme Verlag KG Stuttgart · New York

Cyclic AMP/PKA-Promoted Apoptosis: Insights from Studies of S49 Lymphoma Cells

P. A. Insel
1   Medicine, University of California, San Diego, La Jolla, California, USA
2   Pharmacology, University of California, San Diego, La Jolla, California, USA
,
A. Wilderman
1   Medicine, University of California, San Diego, La Jolla, California, USA
,
L. Zhang
1   Medicine, University of California, San Diego, La Jolla, California, USA
,
M. M. Keshwani
1   Medicine, University of California, San Diego, La Jolla, California, USA
,
A. C. Zambon
1   Medicine, University of California, San Diego, La Jolla, California, USA
› Institutsangaben
Weitere Informationen

Publikationsverlauf

received 03. März 2014

accepted 18. Juni 2014

Publikationsdatum:
16. Juli 2014 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Abstract

Increases in cyclic AMP (cAMP) are pro-apoptotic in numerous cell types, but the mechanisms of cAMP-promoted apoptosis are poorly defined. We have used murine S49 T-lymphoma cells as a model to provide insight into these mechanisms. Increases in cAMP in wild-type (WT) S49 cells were first noted to kill these cells in the 1970 s, but only in recent years, it was shown that this occurs by the intrinsic (mitochondria-dependent) apoptotic pathway. The apoptotic response does not occur in protein kinase A-null (kin-) clonal variants of WT S49 cells and thus is mediated by protein kinase A (PKA). A second S49 clonal variant, cAMP-Deathless (D-), has PKA activity but lacks cAMP-promoted apoptosis. Apoptosis in WT S49 cells occurs many hours after cAMP/PKA-promoted G1 cell cycle arrest and involves increased expression of Bim, a pro-apoptotic member of the Bcl-2 (B-cell lymphoma-2) family. This increase in Bim expression does not occur in kin- or D- S49 cells and knockdown of Bim blunts cAMP-mediated apoptosis in WT cells. Cytotoxic T lymphocyte antigen-2 also appears to contribute to cAMP/PKA-promoted apoptosis of S49 cells. Based on time-dependent differences in gene expression between WT, D- and kin- S49 cells following incubation with 8-(4-chlorophenylthio)-cAMP, additional genes and proteins are likely involved in this apoptosis. Studies with S49 cells should reveal further insight regarding the mechanisms of cAMP/PKA-promoted cell death, including the identification of proteins that are targets to enhance (e. g., in cancer) or inhibit (e. g., cardiac failure) apoptosis in response to hormones, neurotransmitters, and drugs.

Key words

kin- - BIM - CTLA-2 - glucocorticoids - forskolin
 

  • References

  • 1 Insel PA, Zhang L, Murray F, Yokouchi H, Zambon AC. Cyclic AMP is both a pro-apoptotic and anti-apoptotic second messenger. Acta Physiol (Oxf) 2011; 204: 277-287
    PubMedGoogle Scholar
  • 2 Horibata K, Harris AW. Mouse myelomas and lymphomas in culture. Exp Cell Res 1970; 60: 61-77
    CrossrefPubMedGoogle Scholar
  • 3 van Daalen Wetters T, Coffino P. Cultured S49 mouse T lymphoma cells. Methods Enzymol 1987; 151: 9-19
    PubMedGoogle Scholar
  • 4 Sibley CH, Tomkins GM. Mechanisms of steroid resistance. Cell 1974; 2: 221-227
    CrossrefPubMedGoogle Scholar
  • 5 Yamamoto KR, Stampfer MR, Tomkins GM. Receptors from glucocorticoid-sensitive lymphoma cells and two classes of insensitive clones: physical and DNA-binding properties. Proc Nat Acad Sci U S A 1974; 71: 3901-3905
    CrossrefPubMedGoogle Scholar
  • 6 Insel PA, Bourne HR, Coffino P, Tomkins GM. Cyclic AMP-dependent protein kinase: pivotal role in regulation of enzyme induction and growth. Science 1975; 190: 896-898
    CrossrefPubMedGoogle Scholar
  • 7 Hochman J, Insel PA, Bourne HR, Coffino P, Tomkins GM. A structural gene mutation affecting the regulatory subunit of cyclic AMP-dependent protein kinase in mutant lymphoma cells. Proc Natl Acad Sci USA 1975; 72: 5051-5055
    CrossrefPubMedGoogle Scholar
  • 8 Albert DA, Nodzenski E, Yim G, Kowalski J. Effect of cyclic AMP on the cell cycle regulation of ribonucleotide reductase M2 subunit messenger RNA concentrations in wild-type and mutant S49 T lymphoma cells. J Cell Physiol 1990; 143: 251-256
    CrossrefPubMedGoogle Scholar
  • 9 Insel PA, Fenno J. Cyclic AMP-dependent protein kinase mediates a cyclic AMP-stimulated decrease in ornithine and S-adenosylmethionine decarboxylase activities. Proc Natl Acad Sci USA 1978; 75: 862-865
    CrossrefPubMedGoogle Scholar
  • 10 Albert DA. The effect of cyclic-AMP on the regulation of c-myc expression in T-lymphoma cells. J Clin Invest 1995; 95: 1490-1496
    CrossrefPubMedGoogle Scholar
  • 11 Wajeman-Chao SA, Lancaster SA, Graf Jr LH, Chambers DA. Mechanism of catecholamine-mediated destabilization of messenger RNA encoding Thy-1 protein in T-lineage cells. J Immunol 1998; 161: 4825-4833
    PubMedGoogle Scholar
  • 12 Steinberg RA, van Daalen Wetters T, Coffino P. Kinase-negative mutants of S49 mouse lymphoma cells carry a trans-dominant mutation affecting expression of cAMP-dependent protein kinase. Cell 1978; 15: 1351-1361
    CrossrefPubMedGoogle Scholar
  • 13 Orellana SA, McKnight GS. The S49 Kin-cell line transcribes and translates a functional mRNA coding for the catalytic subunit of cAMP-dependent protein kinase. J Biol Chem 1990; 265: 3048-3053
    PubMedGoogle Scholar
  • 14 Steinberg RA. A kinase-negative mutant of S49 mouse lymphoma cells is defective in posttranslational maturation of catalytic subunit of cyclic AMP-dependent protein kinase. Mol Cell Biol 1991; 11: 705-712
    PubMedGoogle Scholar
  • 15 Keshwani MM, Klammt C, von Daake S, Ma Y, Kornev AP, Shoe S, Insel PA, Taylor SS. Cotranslational cis-phosphorylation of the COOH-terminal tail is a key priming step in the maturation of cAMP-dependent protein kinase. Proc Nat Acad Sci USA 2012; 109: E1221-E1229
    CrossrefPubMedGoogle Scholar
  • 16 Lemaire I, Coffino P. Cyclic AMP-induced cytolysis in S49 cells: selection of an unresponsive “deathless” mutant. Cell 1977; 11: 149-155
    CrossrefPubMedGoogle Scholar
  • 17 Bourne HR, Coffino P, Tomkins GM. Selection of a variant lymphoma cell deficient in adenylate cyclase. Science 1975; 187: 750-752
    CrossrefPubMedGoogle Scholar
  • 18 Haga T, Ross EM, Anderson HJ, Gilman AG. Adenylate cyclase permanently uncoupled from hormone receptors in a novel variant of S49 mouse lymphoma cells. Proc Nat Acad Sci USA 1977; 74: 2016-2020
    CrossrefPubMedGoogle Scholar
  • 19 Gilman AG. Nobel Lecture. G proteins and regulation of adenylyl cyclase. Biosci Rep 1995; 15: 65-97
    CrossrefPubMedGoogle Scholar
  • 20 Yan L, Herrmann V, Hofer JK, Insel PA. β-adrenergic receptor/cAMP-mediated signaling and apoptosis of S49 lymphoma cells. Am J Physiol Cell Physiol 2000; 279: C1665-C1674
    PubMedGoogle Scholar
  • 21 Zhang L, Insel PA. Bcl-2 protects lymphoma cells from apoptosis but not growth arrest promoted by cAMP and dexamethasone. Am J Physiol Cell Physiol 2001; 281: C1642-C1647
    PubMedGoogle Scholar
  • 22 Zhang L, Insel PA. The pro-apoptotic protein Bim is a convergence point for cAMP/protein kinase A- and glucocorticoid-promoted apoptosis of lymphoid cells. J Biol Chem 2004; 279: 20858-20865
    CrossrefPubMedGoogle Scholar
  • 23 Zhang L, Zambon AC, Vranizan K, Pothula K, Conklin BR, Insel PA. Gene expression signatures of cAMP/protein kinase A (PKA)-promoted, mitochondrial-dependent apoptosis. Comparative analysis of wild-type and cAMP-deathless S49 lymphoma cells. J Biol Chem 2008; 283: 4304-4313
    CrossrefPubMedGoogle Scholar
  • 24 Lamb D, Steinberg RA. Anti-proliferative effects of 8-chloro-cAMP and other cAMP analogs are unrelated to their effects of protein kinase A regulatory subunit expression. J Cell Physiol 2002; 192: 216-224
    CrossrefPubMedGoogle Scholar
  • 25 Zambon AC, Zhang L, Minovitsky S, Kanter JR, Prabhakar S, Salomonis N, Vranizan K, Dubchak I, Conklin BR, Insel PA. Gene expression patterns define key transcriptional events in cell-cycle regulation by cAMP and protein kinase A. Proc Natl Acad Sci USA 2005; 102: 8561-8566
    CrossrefPubMedGoogle Scholar
  • 26 Gillings AS, Balmanno K, Wiggins CM, Johnson M, Cook SJ. Apoptosis and autophagy: BIM as a mediator of tumour cell death in response to oncogene-targeted therapeutics. FEBS J 2009; 276: 6050-6062
    CrossrefPubMedGoogle Scholar
  • 27 Akiyama T, Tanaka S. Bim: guardian of tissue homeostasis and critical regulator of the immune system, tumorigenesis and bone biology. Arch Immunol Ther Exp (Warsz) 2011; 59: 277-287
    CrossrefPubMedGoogle Scholar
  • 28 Weber K, Harper N, Schwabe J, Cohen GM. BIM-mediated membrane insertion of the BAK pore domain is an essential requirement for apoptosis. Cell Rep 2013; 5: 409-420
    CrossrefPubMedGoogle Scholar
  • 29 Roulston A, Muller WJ, Shore GC. BIM, PUMA and the achilles’ heel of oncogene addiction. Sci Signal 2013; 6: pe12
    PubMedGoogle Scholar
  • 30 Zambon AC, Wilderman A, Ho A, Insel PA. Increased expression of the pro-apoptotic protein BIM, a mechanism for cAMP/protein kinase A (PKA)-induced apoptosis of immature T cells. J Biol Chem 2011; 286: 33260-33267
    CrossrefPubMedGoogle Scholar
  • 31 Suzuki S, Yokoyama U, Abe T, Kiyonari H, Yamashita N, Kato Y, Kurotani R, Sato M, Okumura S, Ishikawa Y. Differential roles of Epac in regulating cell death in neuronal and myocardial cells. J Biol Chem 2010; 285: 24248-24259
    CrossrefPubMedGoogle Scholar
  • 32 Huseby S, Gausdal G, Keen TJ, Kjærland E, Krakstad C, Myhren L, Brønstad K, Kunick C, Schwede F, Genieser HG, Kleppe R, Døskeland SO. Cyclic AMP induces IPC leukemia cell apoptosis via CRE-and CDK-dependent Bim transcription. Cell Death Dis 2011; 2: e237
    CrossrefPubMedGoogle Scholar
  • 33 Nedvetsky PI, Kwon SH, Debnath J, Mostov KE. Cyclic AMP regulates formation of mammary epithelial acini in vitro. Mol Biol Cell 2012; 23: 2973-2981
    CrossrefPubMedGoogle Scholar
  • 34 Lee YY, Moujalled D, Doerflinger M, Gangoda L, Weston R, Rahimi A, de Alboran I, Herold M, Bouillet P, Xu Q, Gao X, Du XJ, Puthalakath H. CREB-binding protein (CBP) regulates β-adrenoceptor (β-AR)-mediated apoptosis. Cell Death Differ 2013; 20: 941-952
    CrossrefPubMedGoogle Scholar
  • 35 Lin DC, Xu L, Ding LW, Sharma A, Liu LZ, Yang H, Tan P, Vadgama J, Karlan BY, Lester J, Urban N, Schummer M, Doan N, Said JW, Sun H, Walsh M, Thomas CJ, Patel P, Yin D, Chan D, Koeffler HP. Genomic and functional characterization of phosphodiesterase subtype 4D in human cancers. Proc Nat Acad Sci USA 2013; 110: 6109-6114
    CrossrefPubMedGoogle Scholar
  • 36 Moujalled D, Weston R, Anderton H, Ninnis R, Goel P, Coley A, Huang DC, Wu L, Strasser A, Puthalakath H. Cyclic-AMP-dependent protein kinase A regulates apoptosis by stabilizing the BH3-only protein Bim. EMBO Rep 2010; 12: 77-83
    PubMedGoogle Scholar
  • 37 Coley AM, Moujalled D, Puthalakath H. The PKA paradox: is Bim the answer?. Cell Cycle 2011; 10: 729-730
    CrossrefPubMedGoogle Scholar
  • 38 Brunet JF, Denizot F, Golstein P. A differential molecular biology search for genes preferentially expressed in functional T lymphocytes: the CTLA genes. Immunol Rev 1988; 103: 21-36
    CrossrefPubMedGoogle Scholar
  • 39 Deshapriya RM, Takeuchi A, Shirao K, Watabe S, Murakami R, Tsujimara H, Yamamoto Y. Drosophila CTLA-2-like protein (D/CTLA-2) inhibits cysteine proteinase 1 (CP1), a cathepsin L-like enzyme. Zoolog Sci 2007; 24: 21-30
    CrossrefPubMedGoogle Scholar
  • 40 Yamamoto Y, Kurata M, Watabe S, Murakami R, Takahashi SY. Novel cysteine proteinase inhibitors homologous to the proregions of cysteine proteinases. Curr Protein Pept Sci 2002; 3: 231-238
    CrossrefPubMedGoogle Scholar
  • 41 Zhang L, Yun H, Murray F, Lu R, Wang L, Hook V, Insel PA. Cytotoxic T lymphocyte antigen-2 alpha induces apoptosis of murine T-lymphoma cells and cardiac fibroblasts and is regulated by cAMP/PKA. Cell Signal 2011; 23: 1611-1616
    CrossrefPubMedGoogle Scholar
  • 42 Denizot F, Brunet JF, Roustan P, Harper K, Suzan M, Luciani MF, Mattei MG, Golstein P. Novel structures CTLA-2 alpha and CTLA-2 beta expressed in mouse activated T cells and mast cells and homologous to cysteine proteinase proregions. Eur J Immunol 1989; 19: 631-635
    CrossrefPubMedGoogle Scholar
  • 43 Delaria K, Fiorentino L, Wallace L, Tamburini P, Brownell E, Muller D. Inhibition of cathepsin L-like cysteine proteases by cytotoxic T-lymphocyte antigen-2 beta. J Biol Chem 1994; 269: 25172-25177
    PubMedGoogle Scholar
  • 44 Zhang L, Murray F, Zahno A, Kanter JR, Chou D, Suda R, Fenlon M, Rassenti L, Cottam H, Kipps TJ, Insel PA. Cyclic nucleotide phosphodiesterase profiling reveals increased expression of phosphodiesterase 7B in chronic lymphocytic leukemia. Proc Nat Acad Sci USA 2008; 105: 19532-19537
    CrossrefPubMedGoogle Scholar
  • 45 Lajevic MD, Suleiman S, Cohen RL, Chambers DA. Activation of p38 mitogen-activated protein kinase by norepinephrine in T-lineage cells. Immunology 2011; 132: 197-208
    CrossrefPubMedGoogle Scholar
  • 46 Gu C, Ma YC, Benjamin J, Littman D, Chao MV, Huang XY. Apoptotic signaling through the beta-adrenergic receptor. A new Gs effector pathway. J Biol Chem 2000; 275: 20726-20733
    CrossrefPubMedGoogle Scholar
  • 47 Wu WW, Wang G, Insel PA, Hsiao CT, Zou S, Martin B, Maudsley S, Shen RF. Discovery- and target-based protein quantification using iTRAQ and pulsed Q collision induced dissociation (PQD). J Proteomics 2012; 75: 2480-2487
    CrossrefPubMedGoogle Scholar
  • 48 Guo Y, Wilderman A, Zhang L, Taylor SS, Insel PA. Quantitative proteomics analysis of the cAMP/protein kinase A signaling pathway. Biochemistry 2012; 51: 9323-9332
    CrossrefPubMedGoogle Scholar
  • 49 Steinberg RA, Coffino P. Two-dimensional gel analysis of cyclic AMP effects in cultured S49 mouse lymphoma cells: protein modification, inductions and repressions. Cell 1979; 18: 719-733
    CrossrefPubMedGoogle Scholar
  • 50 Steinberg RA, Kiss Z. Basal phosphorylation of cyclic AMP-regulated phosphoproteins in intact S49 mouse lymphoma cells. Biochem J 1985; 227: 987-994
    PubMedGoogle Scholar
  • 51 Chan AS, Ng LW, Poon LS, Chan WW, Wong YH. Dopaminergic and adrenergic toxicities on SK-N-MC human neuroblastoma cells are mediated through G protein signaling and oxidative stress. Apoptosis 2007; 12: 167-179
    CrossrefPubMedGoogle Scholar
  • 52 Ferretti AC, Mattaloni SM, Ochoa JE, Larocca MC, Favre C. Protein kinase A signals apoptotic activation in glucose-deprived hepatocytes: participation of reactive oxygen species. Apoptosis 2012; 17: 475-491
    CrossrefPubMedGoogle Scholar
  • 53 Branco AF, Sampaio SF, Wieckowski MR, Sardão VA, Oliveira PJ. Mitochondrial disruption occurs downstream from β-adrenergic overactivation by isoproterenol in differentiated, but not undifferentiated H9c2 cardiomyoblasts: differential activation of stress and survival pathways. Int J Biochem Cell Biol 2013; 45: 2379-2391
    CrossrefPubMedGoogle Scholar
  • 54 Rahimi A, Lee YY, Abdella H, Doerflinger M, Gangoda L, Srivastava R, Xiao K, Ekert PG, Puthalaskath H.. Role of p53 in cAMP/PKA pathway mediated apoptosis. Apoptosis 2013; 18: 1492-1499
    CrossrefPubMedGoogle Scholar
  • 55 Lerner A, Epstein PM. Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies. Biochem J 2006; 393: 21-41
    CrossrefPubMedGoogle Scholar
  • 56 Murray F, Insel PA. Targeting cAMP in chronic lymphocytic leukemia: a pathway-dependent approach for the treatment of leukemia and lymphoma. Expert Opin Ther Targets 2013; 17: 937-949
    Google Scholar
  • 57 Lu D, Aroonsakool N, Yokoyama U, Patel HH, Insel PA. Increase in cellular cAMP concentrations reverses the profibrogenic phenotype of cardiac myofibroblasts: a novel therapeutic approach for cardiac fibrosis. Mol Pharmacol 2013; 84: 787-793
    CrossrefPubMedGoogle Scholar
  • 58 Oikawa M, Wu M, Lim S, Knight WE, Miller CL, Cai Y, Lu Y, Blaxall BC, Takeishi Y, Abe J, Yan C. Cyclic nucleotide phosphodiesterease 3A1 protects the heart against ischemia-reperfusion injury. J Mol Cell Cardiol 2013; 64: 11-19
    CrossrefPubMedGoogle Scholar
  • 59 Zhang X, Szeto C, Gao E, Tang M, Jin J, Fu Q, Makarewich C, Ai X, Li Y, Tang A, Wang J, Gao H, Wang F, Ge XJ, Kunapuli SP, Zhou L, Zeng C, Xiang KY, Chen X. Cardiotoxic and cardioprotective feature of chronic β-adrenergic signaling. Circ Res 2013; 112: 498-509
    CrossrefPubMedGoogle Scholar
  • 60 Li G, Cong L, Gasser J, Zhao J, Chen K, Li F. Mechanisms underlying the anti-proliferative actions of adiponectin in human breast cancer cells, MCF7-dependency on the cAMP/protein kinase-A pathway. Nutr Cancer 2011; 63: 80-88
    PubMedGoogle Scholar
  • 61 Ligumsky H, Wolf I, Israeli S, Haimsohn M, Ferber S, Karasik A, Kaufman B, Rubinek T. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells. Breast Cancer Res Treat 2012; 132: 449-461
    CrossrefPubMedGoogle Scholar
  • 62 Cao W, Ma Z, Rasenick MM, Yeh S, Yu J. N-3 poly-unsaturated fatty acids shift estrogen signaling to inhibit human breast cancer cell growth. PLoS One 2012; 7: e52838
    CrossrefPubMedGoogle Scholar
  • 63 Spina A, Di Maiolo F, Esposito A, D’Auria R, Di Gesto D, Chiosi E, Sorvillo L, Naviglio S. Integrating leptin and cAMP signalling pathways in triple-negative breast cancer cells. Front Biosci (Landmark Ed) 2013; 18: 133-144
    CrossrefPubMedGoogle Scholar
  • 64 Yang L, Wang YL, Liu S, Zhang PP, Chen Z, Liu M, Tang H. miR-181b promotes cell proliferation and reduces apoptosis by repressing the expression of adenylyl cyclase 9 (AC9) in cervical cancer cells. FEBS Lett 2014; 588: 124-130
    CrossrefPubMedGoogle Scholar
  • 65 Appukuttan A, Kasseckert SA, Micoogullari M, Flacke JP, Kumar S, Woste A, Abdallah Y, Pott L, Reusch HP, Ladilov Y. Type 10 adenylyl cyclase mediates mitochondrial Bax translocation and apoptosis of adult rat cardiomyocytes under simulated ischaemia/reperfusion. Cardiovasc Res 2012; 93: 340-349
    CrossrefPubMedGoogle Scholar
  • 66 Chen YX, Allars M, Maiti K, Angeli GL, Abou-Seif C, Smith R, Nicholson RC. Factors affecting cytotrophoblast cell viability and differentiation: Evidence of a link between syncytialisation and apoptosis. Int J Biochem Cell Biol 2011; 43: 821-828
    CrossrefPubMedGoogle Scholar
  • 67 Arnold DE, Gagne C, Niknejad N, McBurney MW, Dimitroulakos J. Lovastatin induces neuronal differentiation and apoptosis of embryonal carcinoma and neuroblastoma cells: enhanced differentiation and apoptosis in combination with dbcAMP. Mol Cell Biochem 2010; 345: 1-11
    CrossrefPubMedGoogle Scholar
  • 68 Salma J, McDermott JC. Suppression of a MEF2-KLF6 survival pathway by PKA signaling promotes apoptosis in embryonic hippocampal neurons. J Neurosci 2012; 32: 2790-2803
    CrossrefPubMedGoogle Scholar
  • 69 Villarruel EQ, Borda E, Sterin-Borda L, Orman B. Lidocaine-induced apoptosis of gingival fibroblasts: participation of cAMP and PKC activity. Cell Biol Int 2011; 35: 783-788
    CrossrefPubMedGoogle Scholar
  • 70 Ku BM, Lee YK, Jeong JY, Ryu J, Choi J, Kim JS, Cho YW, Roh GS, Kim HJ, Cho GJ, Choi WS, Kang SS. Caffeine inhibits cell proliferation and regulates PKA/GSK3β pathways in U87MG human glioma cells. Mol Cells 2011; 31: 275-279
    CrossrefPubMedGoogle Scholar
  • 71 Sugimoto N, Miwa S, Ohno-Shosaku T, Tsuchiya H, Hitomi Y, Nakamura H, Tomita K, Yachie A, Koizumi S. Activation of tumor suppressor protein PTEN and induction of apoptosis are involved in cAMP-mediated inhibition of cell number in B92 glial cells. Neurosci Lett 2011; 497: 55-59
    CrossrefPubMedGoogle Scholar
  • 72 Moon EY, Lee GH, Lee MS, Kim HM, Lee JW. Phosphodiesterase inhibitors control A172 human glioblastoma cell death through cAMP-mediated activation of protein kinase A and Epac1/Rap1 pathways. Life Sci 2012; 90: 373-380
    CrossrefPubMedGoogle Scholar
  • 73 Koehler JA, Kain T, Drucker DJ. Glucagon-like peptide-1 receptor activation inhibits growth and augments apoptosis in murine CT26 colon cancer cells. Endocrinology 2011; 152: 3362-3372
    CrossrefPubMedGoogle Scholar
  • 74 Follin-Arbelet V, Torgersen ML, Naderi EH, Misund K, Sundan A, Blomhoff HK. Death of multiple myeloma cells induced by cAMP-signaling involves downregulation of Mcl-1 via the JAK/STAT pathway. Cancer Lett 2013; 335: 323-331
    CrossrefPubMedGoogle Scholar
  • 75 Park KH, Park HJ, Shin KS, Choi HS, Kai M, Lee MK. Modulation of PC12 cell viability by forskolin-induced cyclic AMP levels through ERK and JNK pathways: an implication for L-DOPA-induced cytotoxicity in nigrostriatal dopamine neurons. Toxicol Sci 2012; 128: 247-257
    CrossrefPubMedGoogle Scholar
  • 76 Leadsham JE, Gourlay CW. cAMP/PKA signaling balances respiratory activity with mitochondria dependent apoptosis via transcriptional regulation. BMC Cell Biol 2010; 11: 92
    CrossrefPubMedGoogle Scholar
  • 77 Loots GG, Ovcharenko I. rVISTA 2.0: evolutionary analysis of transcription factor binding sites. Nucleic Acids Res 2004; W217-W221
    PubMedGoogle Scholar
  • 78 Gilley J, Coffer PJ, Ham J. FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons. J Cell Biol 2003; 162: 613-622
    CrossrefPubMedGoogle Scholar